| 序号 | 股票代码 | 股票名称 | 机构名称 | 变动方向 | 变动股份数(股) | 变动后数量(股) | 变动后持股率 | 公布日期 |
| 801 | 02607 | 上海医药 | Morgan Stanley |
增持 | 31.61万 | 5193.91万 | 6.78% | 2011-09-20 |
| 802 | 02607 | 上海医药 | Morgan Stanley |
增持 | 48.08万 | 5162.30万 | 6.74% | 2011-09-19 |
| 803 | 02607 | 上海医药 | Morgan Stanley |
增持 | 368.41万 | 5114.22万 | 6.68% | 2011-09-16 |
| 804 | 02607 | 上海医药 | Morgan Stanley |
增持 | 42.42万 | 4745.81万 | 6.20% | 2011-09-15 |
| 805 | 02607 | 上海医药 | Morgan Stanley |
增持 | 63.59万 | 4703.39万 | 6.14% | 2011-09-14 |
| 806 | 02607 | 上海医药 | Morgan Stanley |
增持 | 12.20万 | 4639.80万 | 6.06% | 2011-09-12 |
| 807 | 02607 | 上海医药 | Morgan Stanley |
增持 | 41.87万 | 4627.60万 | 6.04% | 2011-09-09 |
| 808 | 02607 | 上海医药 | Morgan Stanley |
增持 | 7.36万 | 4585.73万 | 5.99% | 2011-09-08 |
| 809 | 02607 | 上海医药 | Morgan Stanley |
减持 | -16.51万 | 4578.37万 | 5.98% | 2011-09-07 |
| 810 | 02607 | 上海医药 | Morgan Stanley |
减持 | -21.70万 | 4594.88万 | 5.99% | 2011-09-06 |
| 811 | 02607 | 上海医药 | Morgan Stanley |
增持 | 7300.00 | 4616.58万 | 6.03% | 2011-09-02 |
| 812 | 02607 | 上海医药 | Morgan Stanley |
增持 | 6.10万 | 4615.85万 | 6.03% | 2011-09-01 |
| 813 | 02607 | 上海医药 | Morgan Stanley |
减持 | -8.86万 | 4609.75万 | 6.02% | 2011-08-31 |
| 814 | 02607 | 上海医药 | Morgan Stanley |
减持 | -4.59万 | 4618.61万 | 6.03% | 2011-08-30 |
| 815 | 02607 | 上海医药 | Morgan Stanley |
减持 | -3.57万 | 4623.20万 | 6.04% | 2011-08-26 |
| 816 | 02607 | 上海医药 | Morgan Stanley |
减持 | -2.14万 | 4626.77万 | 6.04% | 2011-08-23 |
| 817 | 02607 | 上海医药 | Temasek Holdings (Private) Limited |
增持 | 181.21万 | 12402.38万 | 16.19% | 2011-08-22 |
| 818 | 02607 | 上海医药 | Morgan Stanley |
增持 | 1.90万 | 4628.91万 | 6.04% | 2011-08-19 |
| 819 | 02607 | 上海医药 | Morgan Stanley |
增持 | 14.37万 | 4627.01万 | 6.04% | 2011-08-18 |
| 820 | 02607 | 上海医药 | Morgan Stanley |
增持 | 10.13万 | 4612.64万 | 6.02% | 2011-08-17 |
| 821 | 02607 | 上海医药 | Temasek Holdings (Private) Limited |
增持 | 282.56万 | 11705.23万 | 15.28% | 2011-08-16 |
| 822 | 02607 | 上海医药 | Morgan Stanley |
减持 | -7.42万 | 4602.51万 | 6.01% | 2011-08-16 |
| 823 | 02607 | 上海医药 | Morgan Stanley |
减持 | -78.00万 | 4609.93万 | 6.02% | 2011-08-15 |
| 824 | 02607 | 上海医药 | Morgan Stanley |
增持 | 57.11万 | 4687.93万 | 6.12% | 2011-08-12 |
| 825 | 02607 | 上海医药 | Morgan Stanley |
增持 | 33.00万 | 4630.82万 | 6.05% | 2011-08-11 |
| 826 | 02607 | 上海医药 | Temasek Holdings (Private) Limited |
增持 | 373.81万 | 10951.80万 | 14.30% | 2011-08-09 |
| 827 | 02607 | 上海医药 | Morgan Stanley |
减持 | -6.95万 | 4599.99万 | 6.01% | 2011-08-03 |
| 828 | 02607 | 上海医药 | Morgan Stanley |
减持 | -10.37万 | 4606.30万 | 6.01% | 2011-07-29 |
| 829 | 02607 | 上海医药 | Morgan Stanley |
增持 | 71.86万 | 4616.67万 | 6.03% | 2011-07-28 |
| 830 | 02607 | 上海医药 | Schroders Plc |
增持 | 182.81万 | 3952.94万 | 5.16% | 2011-07-22 |
| 831 | 02607 | 上海医药 | Morgan Stanley |
增持 | 4.78万 | 4545.48万 | 5.93% | 2011-07-21 |
| 832 | 02607 | 上海医药 | T. Rowe Price Associates, Inc. and its affiliates |
增持 | 229.92万 | 6922.26万 | 9.03% | 2011-07-19 |
| 833 | 02607 | 上海医药 | T. Rowe Price Associates, Inc. and its affiliates |
增持 | 36.64万 | 6127.18万 | 8.00% | 2011-07-12 |
| 834 | 02607 | 上海医药 | JPMorgan Chase & Co. |
增持 | 590.90万 | 6303.41万 | 8.23% | 2011-07-11 |
| 835 | 02607 | 上海医药 | JPMorgan Chase & Co. |
增持 | 121.29万 | 5426.16万 | 7.08% | 2011-06-28 |
| 836 | 02607 | 上海医药 | T. Rowe Price Associates, Inc. and its affiliates |
增持 | 407.69万 | 5576.58万 | 7.28% | 2011-06-23 |
| 837 | 02607 | 上海医药 | Shanghai Industrial Investment (Holdings) Company Limited |
增持 | 20.00万 | 92318.81万 | 48.01% | 2011-06-17 |
| 838 | 02607 | 上海医药 | Goldman Sachs (Asia) Corporate Holdings L.P. |
减持 | -9963.21万 | 0.00万 | 0.00% | 2011-06-17 |
| 839 | 02607 | 上海医药 | Shanghai Pharmaceutical (Group) |
减持 | -208.49万 | 74992.35万 | 39.00% | 2011-06-17 |
| 840 | 02607 | 上海医药 | Shanghai Industrial Investment (Holdings) Company Limited |
减持 | -252.81万 | 92298.81万 | 48.00% | 2011-06-17 |
| 841 | 02607 | 上海医药 | The Goldman Sachs Group, Inc. |
减持 | -9963.21万 | 0.00万 | 0.00% | 2011-06-17 |
| 842 | 02607 | 上海医药 | Shanghai Shangshi (Group) Co., Ltd. |
减持 | -252.81万 | 92298.81万 | 48.00% | 2011-06-17 |
| 843 | 02607 | 上海医药 | Shanghai Shangshi (Group) Co., Ltd. |
增持 | 20.00万 | 92318.81万 | 48.01% | 2011-06-17 |
| 844 | 02607 | 上海医药 | Goldman Sachs (Asia) L L C |
减持 | -9963.21万 | 0.00万 | 0.00% | 2011-06-17 |
| 845 | 02607 | 上海医药 | Goldman Sachs Holdings (Hong Kong) Limited |
减持 | -9963.21万 | 0.00万 | 0.00% | 2011-06-17 |
| 846 | 02607 | 上海医药 | GS India Holdings (Delaware) L.L.C. |
减持 | -9963.21万 | 0.00万 | 0.00% | 2011-06-17 |
| 847 | 02607 | 上海医药 | JPMorgan Chase & Co. |
增持 | 97.81万 | 4445.25万 | 6.08% | 2011-06-15 |
| 848 | 02607 | 上海医药 | JPMorgan Chase & Co. |
增持 | 1392.27万 | 4347.44万 | 5.95% | 2011-06-14 |
| 849 | 02607 | 上海医药 | T. Rowe Price Associates, Inc. and its affiliates |
增持 | 129.41万 | 4430.53万 | 6.06% | 2011-06-13 |
| 850 | 02607 | 上海医药 | Deutsche Bank Aktiengesellschaft |
减持 | -9963.21万 | 110.00万 | 0.14% | 2011-06-11 |